BANK OF AMERICA CORP /DE/ - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,663,472
+14.9%
692,274
+68.2%
0.00%0.0%
Q2 2023$6,669,864
-53.3%
411,466
-52.1%
0.00%0.0%
Q1 2023$14,289,780
+1468.8%
858,245
+785.7%
0.00%
Q4 2022$910,860
+184.6%
96,900
-17.7%
0.00%
Q3 2022$320,000
-8.3%
117,780
-2.5%
0.00%
Q2 2022$349,000
+129.6%
120,861
+139.0%
0.00%
Q1 2022$152,000
-39.4%
50,563
-7.4%
0.00%
Q4 2021$251,000
-86.3%
54,621
-81.3%
0.00%
Q3 2021$1,837,000
+10.4%
292,582
+5.3%
0.00%
Q2 2021$1,664,000
-32.4%
277,743
-28.6%
0.00%
Q1 2021$2,461,000
+74.4%
389,086
+55.3%
0.00%
Q4 2020$1,411,000
-19.1%
250,618
-16.4%
0.00%
Q3 2020$1,745,000
-18.5%
299,918
+1.0%
0.00%
Q2 2020$2,141,000
+62.9%
297,013
+5.7%
0.00%
Q1 2020$1,314,000
-38.8%
280,959
+4.9%
0.00%
Q4 2019$2,148,000
-0.6%
267,879
-14.7%
0.00%
Q3 2019$2,160,000
-52.6%
314,150
-42.7%
0.00%
-100.0%
Q2 2019$4,555,000
-49.1%
548,595
-39.0%
0.00%0.0%
Q1 2019$8,945,000
+363.0%
900,014
+256.3%
0.00%
Q4 2018$1,932,000
+973.3%
252,609
+2349.4%
0.00%
Q3 2018$180,000
+80.0%
10,313
-1.6%
0.00%
Q2 2018$100,000
+40.8%
10,486
-35.6%
0.00%
Q1 2018$71,00016,2760.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders